HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Oliver Tunstall Selected Research

emicizumab

11/2021Immune tolerance induction in severe haemophilia A: A UKHCDO inhibitor and paediatric working party consensus update.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Oliver Tunstall Research Topics

Disease

2Hemophilia A (Haemophilia)
11/2021 - 02/2015
2Hemorrhage
11/2021 - 02/2015
1Down Syndrome (Down's Syndrome)
10/2016
1Neoplasms (Cancer)
05/2016
1Thrombophilia
05/2016
1Brain Diseases (Brain Disorder)
01/2016
1Antiphospholipid Syndrome (Antiphospholipid Antibody Syndrome)
07/2013

Drug/Important Bio-Agent (IBA)

1emicizumabIBA
11/2021
1Transcription Factors (Transcription Factor)IBA
10/2016
1Combined Oral ContraceptivesIBA
05/2016
1Imatinib Mesylate (Gleevec)FDA Link
01/2016
1Factor VIII (Coagulation Factor VIII)IBA
02/2015
1Lupus Coagulation Inhibitor (Lupus Anticoagulant)IBA
07/2013

Therapy/Procedure

1Therapeutics
11/2021